In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved. Using NFTs, they suggest consumers in the cannabis industry could generate a product and benefit from it too.
The post User-Generated Data Brings Revenue: It’s Time for the Users to Get Some appeared first on Cannabis Industry Journal.
In this op-ed, Johnson suggests cannabis industry infighting and stakeholders more concerned with profits over public health only hurts the greater cause. He thinks prohibition should be the enemy, not Delta 8.
The post The Real Reason Some Industry Leaders Want Delta 8 Banned appeared first on Cannabis Industry Journal.
On the road to nationwide legalization, cannabis and spirits share similar stories. But here’s the one step the cannabis industry should avoid copying, if it can.
The post Can Cannabis Avoid Alcohol’s 3-Tier Distribution System? appeared first on Cannabis Industry Journal.
In this op-ed, Makwana makes the case for putting environmental sustainability at top of mind for the sake of improving bottom lines in the years to come.
The post Too Many Cannabis Firms Put Sustainability in Last Place appeared first on Cannabis Industry Journal.
With New York, New Jersey and Virginia legalizing adult use cannabis recently, there are a lot of new market opportunities afoot on the East Coast. In this piece, Chistov analyzes how the market differentiates from the West.
The post A Look at the Rise Of The East Coast Cannabis Market appeared first on Cannabis Industry Journal.
In this op-ed, Maxim Mikheev argues that using biosynthesis to produce cannabinoids could be more environmentally sustainable than commercial scale cultivation.
The post Reduce Environmental Impact of Cannabinoid Production Through Biosynthesis appeared first on Cannabis Industry Journal.
There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.